Clinical Trials Browser

Bortezomib × Myeloid × 30 days × Clear all

Carcinoma, Non-Small-Cell Lung, Multiple Myeloma, Neoplasm Metastasis, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT02211755 2026-04-20

Trial of the Combination of Bortezomib and Clofarabine in Adults With Relapsed Solid Tumors

Phase 1 Completed

28 enrolled

LymphoidMyeloid

Lymphoma, Myelodysplastic Syndromes, Neoplasms

Clinical Trials

Natural Killer Cells and Bortezomib to Treat Cancer

Trial of the Combination of Bortezomib and Clofarabine in Adults With Relapsed Solid Tumors